Oral Curcumin (Meriva) Is Effective as an Adjuvant Treatment and Is Able to Reduce IL-22 Serum Levels in Patients with Psoriasis Vulgaris

The Role of Etanercept on the Expression of Markers of T Helper 17 Cells and Their Precursors in Skin Lesions of Patients with Psoriasis Vulgaris

(2017) E. Antiga et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

To study the effect of curcumin on the growth properties of circulating endothelial progenitor cells

(2015) Deepti Vyas et al.   IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

The Multifaceted Role of Curcumin in Cancer Prevention and Treatment

(2015) Muthu Shanmugam et al.   MOLECULES

Immunology of Psoriasis

(2014) Michelle A. Lowes et al.   Annual Review of Immunology

Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols

(2014) Subash C. Gupta et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

An increased proportion of circulating Th22 and Tc22 cells in psoriasis

(2014) Li Luan et al.   CELLULAR IMMUNOLOGY

Differential expression and regulation of prohibitin during curcumin-induced apoptosis of immortalized human epidermal HaCaT cells

(2014) HAI-BO YANG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers

(2013) Bharat B Aggarwal et al.   BRITISH JOURNAL OF PHARMACOLOGY

Serum Levels of Selected Th17 and Th22 Cytokines in Psoriatic Patients

(2013) Anna Michalak-Stoma et al.   DISEASE MARKERS

Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice

(2013) Jun Sun et al.   PLoS One

Curcumin Attenuates Acute Graft-versus-Host Disease Severity via In Vivo Regulations on Th1, Th17 and Regulatory T Cells

(2013) Min-Jung Park et al.   PLoS One

Th17 and Th22 cells in psoriatic arthritis and psoriasis

(2013) Helen Benham et al.   ARTHRITIS RESEARCH & THERAPY

Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials

(2012) Subash C. Gupta et al.   AAPS Journal

Curcumin: a potential candidate for matrix metalloproteinase inhibitors

(2012) Dileep Kumar et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Etanercept Downregulates the Th17 Pathway and Decreases the IL-17+/IL-10+ Cell Ratio in Patients with Psoriasis Vulgaris

(2012) Emiliano Antiga et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Differential regulation of CD4+ T helper cell responses by curcumin in experimental autoimmune encephalomyelitis

(2012) Saravanan Kanakasabai et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Comparative Absorption of a Standardized Curcuminoid Mixture and Its Lecithin Formulation

(2011) John Cuomo et al.   JOURNAL OF NATURAL PRODUCTS

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma

(2011) Reason Wilken et al.   Molecular Cancer

Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment

(2011) Purusotam Basnet et al.   MOLECULES

Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies

(2010) Jenny Epstein et al.   BRITISH JOURNAL OF NUTRITION

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

(2009) Stefanie Eyerich et al.   JOURNAL OF CLINICAL INVESTIGATION

Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial

(2008) M. Caproni et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Human interleukin 17–producing cells originate from a CD161+CD4+T cell precursor

(2008) Lorenzo Cosmi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial

(2008) Shanu Kohli Kurd et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Curcumin as “Curecumin”: From kitchen to clinic

(2007) Ajay Goel et al.   BIOCHEMICAL PHARMACOLOGY